Mitchell Sabloff
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Mesenchymal stem cell research
Papers in
- Hematology 46
- Hematopoietic Stem Cell Transplantation 29
- Acute Myeloid Leukemia Research 27
- Chronic Myeloid Leukemia Treatments 4
-
- Acute Lymphoblastic Leukemia research 18
- Co-authors
- David Allan (25 shared papers)Christopher Bredeson (31 shared papers)Robert Peter Gale (5 shared papers)Lothar Huebsch (22 shared papers)Vikas Gupta (4 shared papers)Harold Atkins (16 shared papers)Mary Eapen (5 shared papers)Sheryl McDiarmid (8 shared papers)
- Journals
- Blood (19 papers)Biology of Blood and Marrow Transplantation (7 papers)Leukemia Research (3 papers)Transplantation and Cellular Therapy (3 papers)Radiotherapy and Oncology (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mitchell Sabloff
64 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 75
- Hematology 955
- Genetics 279
- Transplantation 63
- Public Health, Environmental and Occupational Health 336
- Oncology 307
Countries citing papers authored by Mitchell Sabloff
This map shows the geographic impact of Mitchell Sabloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Sabloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Sabloff more than expected).
Fields of papers citing papers by Mitchell Sabloff
This network shows the impact of papers produced by Mitchell Sabloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Sabloff. The network helps show where Mitchell Sabloff may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell Sabloff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 156 | |
| 2 | 2010 | 135 | |
| 3 | 2010 | 123 | |
| 4 | 2010 | 120 | |
| 5 | 2013 | 88 | |
| 6 | 2010 | 87 | |
| 7 | 2016 | 74 | |
| 8 | 2017 | 73 | |
| 9 | 2015 | 58 | |
| 10 | 2007 | 42 | |
| 11 | 2015 | 38 | |
| 12 | 2014 | 38 | |
| 13 | 2018 | 37 | |
| 14 | 2021 | 36 | |
| 15 | 1991 | 28 | |
| 16 | 2017 | 27 | |
| 17 | 2014 | 27 | |
| 18 | 2008 | 24 | |
| 19 | 2006 | 21 | |
| 20 | 2011 | 21 |
About Mitchell Sabloff
Mitchell Sabloff is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Genetics and Immunology, having authored 68 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (29 papers), Acute Myeloid Leukemia Research (27 papers), Acute Lymphoblastic Leukemia research (18 papers), Lymphoma Diagnosis and Treatment (6 papers), Polyomavirus and related diseases (5 papers), Hemoglobinopathies and Related Disorders (4 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (955 citations), Genetics (279 citations), Transplantation (63 citations), Public Health, Environmental and Occupational Health (336 citations) and Oncology (307 citations). Mitchell Sabloff has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include David Allan, Christopher Bredeson, Robert Peter Gale, Lothar Huebsch, Vikas Gupta, Harold Atkins, Mary Eapen, Sheryl McDiarmid, Michael Rosu‐Myles and Yevgeniya Le. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Leukemia Research, Transplantation and Cellular Therapy and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.